info@auctorespublishing.com
+1-(302)-520-2644
+1-(302)-520-2644

Role of Insulin: Perspectives

  1. Home
  2. Journals
  3. Diabetes and Islet Biology
  4. Current Issues
Submit Guidelines

Research Article | DOI: https://doi.org/10.31579/2641-8975/030

Role of Insulin: Perspectives

  • Gudisa Bereda ID 1*

1 Department of Pharmacy, Negelle Health Science College, Guji, Ethiopia. 

*Corresponding Author: Gudisa Bereda , Department of Pharmacy, Negelle Health Science College, Guji, Ethiopia.

Citation: Gudisa Bereda, (2022). Role of Insulin: Perspectives. J. Diabetes and Islet Biology, 5(1); DOI:10.31579/2641-8975/030

Copyright: © 2022 Gudisa Bereda, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received: 03 December 2021 | Accepted: 31 December 2021 | Published: 10 January 2022

Keywords: insulin; role

Abstract

The pancreas in a non-diabetic patient invariably produces a lesser quantum of insulin (basal production). Insulin furnishes glucose homeostasis by keeping the plasma glucose worth in an optimum class throughout the day. It assists transport blood glucose into the body cells where the glucose is metabolized to generate energy. Regular insulin is inserted pre-meal to abrupt the postprandial ascend in glucose levels. It figures hexamers after insertion into the subcutaneous space sluggishing its absorption. Ultra-fast acting commences to act 4-7 minutes before regular apidra and lasts for around 3 hours. The absorption rate of lente insulin is downgraded by the extension of zinc to the insulin preparation. Long-acting insulins furnish basal insulin coverage. Atrophy of subcutaneous fat owing to applicability of further greater accumulated insulin preparations of neutral potenz hydrogen. 

Introduction

The discovery of insulin and function

Insulin is a significant polypeptide hormone that regulates carbohydrate metabolism. Insulin is derived from the Latin word insula denotation "island" because the hormone is generated in the islets of langerhans. It was ascertained by Banting and Best in 1921-1922 at the University of Toronto [1]. Insulin is a peptide hormone that is produced and generated by beta cells in the Langerhans islets of the pancreas. A metabolic infirmity called diabetes happens as a sequence of insufficient insulin activity in the body or the degeneration in insulin production in beta cells. Thereupon, the find out of insulin has been a revolutionary climax in knowing both the treatment and auguring of diabetes [2, 3]. The pancreas in a non-diabetic patient invariably produces a lesser quantum of insulin (basal production) [4]. After meals, a greater quantum of insulin is produced (bolus generation) to tolerate the escalated blood glucose that happens succeeding a meal [5]. The metabolism of glucose is actuated by food input, leading to coincidentally accelerated β- cell insulin secretion and de-escalated β- cell glucagon production to yield serum glucose levels back to normal [6]. Succeeding production, insulin systemically circulates and is distributed to hepatocytes, which are quicker to deposit glucose in the figure of glycogen. Skeletal muscle cells and adipocytes, the distinctive considerable targets of circulating insulin, also take up glucose, thereby decreasing the blood glucose accumulation to commencement [7]. As with distinctive protein hormones, insulin actuates glucose uptake, and skeletal muscle protein production, glycogenesis, and lipogenesis through the tyrosine kinase receptor pathway [8, 9].

The structure of insulin: 

Insulin has 51 amino acids and 6000 Da molecular weight in nearly entire species, involving human. The human insulin molecule contains of dual polypeptide chains, lone “A” chain and lone “B” chain consisting 21 and 30 amino acid debris, respectively. These two chains are interlinked by SS (CysA7-CysB7 and CysA20-CysA19) with a disulfide bond, and an additional disulfide bond links CysA6 and CysA11 in chain A. The amino acids of the dual chains also partake in multiplex non-covalent interactions [10, 11].

Figure-1. Schematic exemplify of human proinsulin structure

Factors enliven insulin production: Glucose, amino acids (leucine, arginine), hormones such as GLP-1, GIP, glucagon, great accumulations of fatty acids, and β-adrenergic sympathetic activity, Stimulatory medications are sulfonylureas, meglitinide and nateglinide, isoproterenol, and acetylcholine [12].

Factors suppress insulin production: Epinephrine is the great significant inhibitor, in emergency circumstances like stress, exercise and trauma, the nervous system enlivens adrenal medulla to secrete epinephrine and inhibit insulin generation [13].

The function of insulin: Insulin furnishes glucose homeostasis by considering the plasma glucose worth in an optimum class throughout the day [14]. It assists transport blood glucose into the body cells where the glucose is metabolized to generate energy. It vindicates glucose accumulation in the blood. When glucose accumulation in the blood is escalated, insulin smaller it by accelerating glucose uptake by muscle, liver and fat cells [15]. Surplus glucose is transformed to glycogen by these tissues. When glucose accumulation is downgraded in the blood, glycogen is transformed back to glucose and released in the blood. It is enclosed in regulating amino acid uptake by escalating DNA duplication and protein production [16]. Insulin facilitates fatty acid generation via the uptake of lipid from blood by fat cells. It also de-escalates proteinolysis, lipolysis and gluconeogenesis [17, 18]. It adjusts carbohydrate, fat, and protein metabolism by furnishing glucose in the blood to pass to fat, liver and skeletal muscle cells [19].

Sources of insulin: Human insulin is manufactured by bacterial recombinant DNA technology [20].  Remodeling of the amino acid resultant of human insulin has secreted insulins with otherness pharmacokinetic properties. The commencement of deed, peak consequence and lifetime of deed ascertained by insulin type and by physical and chemical figure of the insulin [21]. Insulin preparation is different in their times of commencement of activity and in their lifetimes of activity. This is owing to otherness in the amino acid resultants of the polypeptides, instance’s dose, site of insertion, blood supplement, temperature, and physical activity can influence the lifetime of deed of the different preparations [22]. The applicable figures categorize from rapid-acting to long-acting [23]. The different insulin types applicable are: 

  1. Rapid acting/rapid-onset and ultrashort-acting insulin preparations: 

(1a) Regular insulin: Regular insulin is injected pre-meal to abrupt the postprandial ascend in glucose levels. It figures hexamers after injection into the subcutaneous area sluggishing its absorption [24, 25]. It is short-acting, soluble, crystalline zinc insulin. It is ordinarily bestowed subcutaneously (or intravenously in emergencies). It rapidly lesser blood sugar and are securely used in pregnancy [26]. 

(1b)Ultrashort-acting insulin: Grouped as ultrashort-acting insulins (because of their fast commencement and short lifetime of deed) [27]. These factors proffer further adjustable treatment regimens and minimize the pitfall of hypoglycemia and used in pregnancy solely if clearly necessitated. Commences to function in 15 minutes, peak near 1 hour and proceeds to function for around 2-4 hours [28].

Insulin lispro, insulin aspart and insulin glulisine: Insulin lispro is (Humalog) sequences from the reversal of the B28 (proline) and B29 (lysine) amino acid resultant of insulin [29]. Insulin lispro has been attested for injection before and incontinently after a meal. Post-meal insulin dosing is applicable for parents of young children with type 1 diabetes, in whom the quantum of carbohydrates consumed at a meal can be unpredictable [30, 31]]. Insulin aspart is distinctive from human insulin by a substitution of the B28 amino acid proline with aspartic acid. Chemically it is B28-aspartic acid-human insulin. Fast-acting aspart adds two excipients, niacinamide and L-arginine, to conventional aspart [32]: Insulin glulisine disparate from human insulin by revamps’ in the amino acid asparagine at place B3 to lysine and the lysine at place B29 to glutamic acid. Chemically, it is 3B-lysine-29B-glutamic acid-human insulin. 

(2) Ultra-fast acting: Apidra (Fiasp) Which commences to act 4-7 minutes before regular apidra and lasts for near 3 hours [33]. 

(3) Short acting: Achieves systemic circulation in 30 min, peaks after around 2-3 hours and stays active for about 3-6 hours. Instances of these preparations involve Actrapid, Humulin, Hypurin and Neutral. This insulin analogous should be injected into the body 20-30 min before meal so as to obtain optimal insulin activity for carbohydrate metabolism [34].

(4) Intermediately acting: Intermediate-acting insulin preparations: 

(4a) Lente insulin: Lente word comes from the Latin "lentus," denotation slow, or sluggish) insulin [35]. The absorption rate of lente insulin is de-escalated by the extension of zinc to the insulin preparation. Its commencement of deed and peak consequence are smaller than those of regular insulin, but are sustained for a lengthy period.  Not convenient for intravenous administration [36]. 

(4b) Isophane NPH insulin suspension: Neutral protamine Hagedorn insulin: The absorption rate of NPH insulin is downgraded by the extension of protamine to the insulin preparation. NPH insulin is intermediate-acting insulin, whose commencement of deed is comparatively 2 hours; peak consequence is 6-14 hours, and lifetime of deed of 10-16 hours (basing on the size of the dose). Because of its wide peak and lengthy lifetime of deed, NPH can guarantee as basal insulin solely when dosed at bedtime or basal and prandial insulin when dosed in the morning [37, 38]. It is a suspension of crystalline zinc insulin joined at neutral pH with a positivelycharged polypeptide, protamine.  Its lifetime of deed is intermediate (owing to holding pattern absorption of the insulin because of its conjugation with protamine, figuring a least soluble complex) [39]. It should solely be bestowed subcutaneously. It is serviceable in treating entire figures of diabetes exclude diabetic ketoacidosis or emergency hyperglycemia. Commencement of deed after 2-4 hours peaks 4-12 hours later and stays active for near 12-18 hours [40]. 

(5) Long acting: long-acting insulin preparations: Long-acting insulins furnish basal insulin content. Basal insulins inhibit hepatic gluconeogenesis to obviate glucose levels from ascending during the fasting state in insulin-defective patients. Aid patients with type 1 diabetes, basal insulins furthermore obviate ketogenesis [41].Long-acting insulin can assist a person with diabetes regulate blood glucose outside of mealtimes [42]. 

(5a)Insulin glargine: The biological activity of insulin glargine is owing to its absorption kinetics and not an otherness pharmacodynamic activity (e.g., enliven of peripheral glucose uptake) [43]. Its further concordant rate of absorption and dearth of an important peak deed sequence in de-escalated nocturnal hypoglycemia when insulin glargine is used at bedtime analogized with NPH insulin [44, 45]. The isoelectric point of insulin glargine is smaller than that of human insulin, leading to precipitousness at the injection site (prolonging its deed). It is smaller in commencement than NPH insulin and has extended hypoglycemic consequence. It has no peak (peakless) [46]. (5b)Insulin detemir: Insulin detemir is sluggishly absorbed owing to its durable consociation with albumin in the SQ tissue. Patients who proficiency an ascend in glucose levels in the hours preceding to a once quotidian injection owing to the waning deed of detemir should use a twice daily dosing regimen. It has consummate currently advanced long-acting insulin analogous [47, 48]. It is consociated with than NPH insulin. Has a dose-dependent hypoglycemic consequence and commencement of deed of 1-2 hours.  Insulin detemir lifetime of deed is greater than 24 hours.  It is bestowed twice daily and gradually absorbed from injection site owing to idiomatic preparation. Its activity can class from 18-24 hours. The ultra-long acting insulin degludec has plasma accumulations measurable besides 24 hours permitting for adjustable dosing [49, 50].

Insulin combinations: Different premixed combinations of human insulins [51]: Such as 70% NPH insulin + 30% regular insulin; 50% NPL insulin + 50% lispro insulin; 75 % NPL insulin + 25% lispro insulin.

Insulin administration: It is administered by SQ injection, insulin is a polypeptide (it is breakdown in the gastrointestinal tract if taken orally). Regular insulin is bestowed I.V. injection in hyperglycemic emergency and I.V. infusion (to void multiplex injections) [52-54]. 

Basal-plus insulin: The extension of a single prandial insulin injection to the already existing basal regimen before the chief meal or the meal concordant with greatest PPG is referred to as a “basal-plus” technique [55, 56]. 

Basal-bolus regimen: Basal-bolus regimen is an amplified insulin therapy when target glycaemic control is not reached with basal insulin. This regimen imitates the physiological insulin production from the pancreas. The intermediate or long acting insulin is bestowed as basal insulin. The rapid or short acting insulin is bestowed as bolus insulin before meal. This regimen seeks often and active self-monitoring, knowledge on insulin-carbohydrate ratio and CF, and titration of insulin dose to reach target glycaemic control [57, 58]. 

When you inject insulin, you should [59-61]: Use a fresh needle every time; conform you are bestowing the right type and dose of insulin; premier the needle every time to put off air and launch the circulate of insulin (also known as an “air shot”); insinuate the needle at 90 degrees (a right angle), if not considered differently by your health professional; after inserting the insulin, hang on to the needle beneath the skin for 10 seconds to make sure you obtain the full dose; revolve insertion sites so that you use a distinctive site any time to escape advancing fatty clots; if using an insulin pen, put off the needle from the pen after each injection; dispose of entire sharps. 

Do not: Use the insulin after the expiry date; use the insulin if it doesn’t appear the pace it should, or if it has been frozen or liable to excessive heat; shake the insulin too hard; insert in demesnes where there are scars, embellish labels or clots; inject through your clothes. 

Storing insulin [62-64]: It’s significant to store insulin appropriately: Store your unopened insulin in the fridge (away from the freezer/chiller section). Don’t let your insulin freeze; preserve the insulin you are using at room temperature (below 25 degrees Celsius). Once insulin has been opened, it can remain at this temperature for up to 28 days; it’s fine to preserve your recent insulin pen in your handbag or bag; don’t preserve it in a place where it might get hot, like in your car or near a window; once open, dispose after 28 days.

Adverse reactions to insulin: (1) Hypoglycemia (further ubiquitous) owing to over dose (tachycardia, confusion, vertigo, diaphoresis) [65]: This type of hypoglycemia necessitated prompt counteract. Treatment of hypoglycemia:If the victim is conscious bestow him/her orange juice, glucose, Sugar containing beverage, food and also if the victim is unconscious (solemn hypoglycemia) use intravenous infusion of 20-50 mL of 50% glucose solution over a 2-3 minute. In the absence of intravenous infusion, 1 mg of glucagon (SQ or IM administration), renew consciousness within around 15 minutes then food consumption lipodystrophy. (2) Atrophy of SQ fat owing to applicability of further greatly accumulated insulin preparations of neutral pH. If insulin is inserted redundantly at the similar site of injection hypertrophy of SQ fatty tissue is happen [66]. (3) Allergic, and local injection site reaction occur with instantaneous type hypersensitivity, seldom urticaria pursues histamine release from tissue mast cells (sensitized by anti-insulin IgE antibodies) [67]. This allergic reaction treated by antihistamines, especially corticosteroids. (4) Weight gain [68]. (5) Insulin immune resistance owing to great titer circulating IgG anti-insulin antibodies [69]. 

Note: Diabetics with renal insufficiency perhaps need adjustment of the insulin dose [70]

Conclusion

Insulin is a peptide hormone that is generated and produced by beta cells in the Langerhans islets of the pancreas. A metabolic infirmity called diabetes happens as a sequence of insufficient insulin activity in the body or the degeneration in insulin production in beta cells. The foremost outcomes of insulin are: (i) In the liver, to enliven glucose oxidation and storage of glucose (glycogenesis), as well as to transform glucose into triglycerides and protein secretion, (ii) in the muscle tissue, it furnishes glucose uptake into the cells, and be stored as glycogen, (iii) and in fat tissue, it furnishes glucose uptake and transformation to triglycerides for storage. Regular insulin is injected pre-meal to abrupt the postprandial ascend in glucose levels. Short acting are achieves systemic circulation in 30 min, peaks after around 2-3 hours and stays active for about 3-6 hours

Abbreviations

ADRs: Adverse drug reactions; CF: Correction factors; CYP450: cytochrome P450; DI: Drug interaction; GIP: Glucose-dependent insulinotropic Polypeptide; GLP-1: Glucagon-like Polypeptide-1; PH: Potenz Hydrogen; P-gp: Pglycoprotein

Acknowledgments

The authors acknowledged Endnote-8, Google scholar, Medscape, Wikipedia, and PubMed.

Data Sources: Sources searched include Google Scholar, Research Gate, PubMed, NCBI, NDSS, PMID, PMCID, and Cochrane database. Search terms included: insulin function, type, side effects etc

Funding 

None 

References

  1. Lewis, G.F.; Brubaker, P.L. The discovery of insulin revisited: Lessons for the modern era. J. Clin. Investig. 2021, 131, e142239.
    View at Publisher | View at Google Scholar
  2. Vecchio I, Tornali C, Bragazzi NL, Martini M. The Discovery of Insulin: An Important Milestone in the History of Medicine. Front Endocrinol (Lausanne) 2018; 9:613.
    View at Publisher | View at Google Scholar
  3. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care 2009; 33(Suppl 1):62-9.
    View at Publisher | View at Google Scholar
  4. Bolli GB, Porcellati F, Lucidi P, Fanelli CG. The physiological basis of insulin therapy in people with diabetes mellitus. Diabetes Research and Clinical Practice. 2021 May 1; 175:108839.
    View at Publisher | View at Google Scholar
  5. Lamont BJ, Waters MF, Andrikopoulos S. A low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or β-cell mass in NZO mice. Nutrition & diabetes. 2016 Feb; 6(2):e194-.
    View at Publisher | View at Google Scholar
  6. Vasiljevic, J.; Torkko, J.M.; Knoch, K.P.; Solimena, M. The making of insulin in health and disease. Diabetologia 2020, 63, 1981–1989.
    View at Publisher | View at Google Scholar
  7. Suckale, J.; Solimena, M. The insulin secretory granule as a signaling hub. Trends Endocrinol. Metab. 2010, 21, 599–609.
    View at Publisher | View at Google Scholar
  8. Yang, B.Y.; Zhai, G.; Gong, Y.L.; Su, J.Z.; Peng, X.Y.; Shang, G.H.; Han, D.; Jin, J.Y.; Liu, H.K.; Du, Z.Y.; et al. Different physiological roles of insulin receptors in mediating nutrient metabolism in zebrafish. Am. J. Physiol. Endocrinol. Metab. 2018, 315, E38–E51.
    View at Publisher | View at Google Scholar
  9. Lankisch MR, Ferlinz KC, Leahy JL, Scherbaum WA, Orals plus Apidra and LANTUS (OPAL) Study Group (2008) Introducing a simplified approach to insulin therapy in type 2 diabetes: A comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral anti-diabetic drugs. Diabetes Obes Metab 10: 1178-1185.
    View at Publisher | View at Google Scholar
  10. Steiner DF, Chan SJ, Welsh JM, Kwok SC. Structure and evolution of the insulin gene. Annu Rev Genet 1985; 19:463-84.
    View at Publisher | View at Google Scholar
  11. Derewenda U, Derewenda Z, Dodson GG, Hubbard RE, Korber F. Molecular structure of insulin: the insulin monomer and its assembly. Br Med Bull 1989; 45:4-18.
    View at Publisher | View at Google Scholar
  12. Kennedy MS, Masharani U. Pancreatic hormones & antidiabetic drugs. Basic and Clinical Pharmacology. New York: McGraw-Hill. 2018:747-1.
    View at Publisher | View at Google Scholar
  13. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nature reviews immunology. 2011 Sep; 11(9):607-15.
    View at Publisher | View at Google Scholar
  14. Qinna NA, Badwan AA. Impact of streptozotocin on altering normal glucose homeostasis during insulin testing in diabetic rats compared to normoglycemic rats. Drug design, development and therapy. 2015; 9:2515.
    View at Publisher | View at Google Scholar
  15. Güemes M, Rahman SA, Hussain K. What is a normal blood glucose?. Archives of disease in childhood. 2016 Jun 1; 101(6):569-74.
    View at Publisher | View at Google Scholar
  16. Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nature reviews Molecular cell biology. 2019 Jul; 20(7):436-50.
    View at Publisher | View at Google Scholar
  17. Vecchio, I.; Tornali, C.; Bragazzi, N.L.; Martini, M. The Discovery of Insulin: An Important Milestone in the History of Medicine. Front. Endocrinol. 2018, 9, 613.
    View at Publisher | View at Google Scholar
  18. Csajbok, E.A.; Tamas, G. Cerebral cortex: A target and source of insulin? Diabetologia 2016, 59, 1609–1615.
    View at Publisher | View at Google Scholar
  19. AL O, EX F, RIMENTAL P, BASIC ME, IEN S. Insulin Structure, Function and Diabetes Models in Animals. Journal of Experimental and Basic Medical Sciences. 2020; 1(3):96-101.
    View at Publisher | View at Google Scholar
  20. Stryjewska A, Kiepura K, Librowski T, Lochyński S. Biotechnology and genetic engineering in the new drug development. Part I. DNA technology and recombinant proteins. Pharmacological reports. 2013 Sep; 65(5):1075-85.
    View at Publisher | View at Google Scholar
  21. Hirsch IB, Juneja R, Beals JM, Antalis CJ, Wright Jr EE. The evolution of insulin and how it informs therapy and treatment choices. Endocrine reviews. 2020 Oct; 41(5):733-55.
    View at Publisher | View at Google Scholar
  22. Akbarian M, Ghasemi Y, Uversky VN, Yousefi R. Chemical modifications of insulin: Finding a compromise between stability and pharmaceutical performance. International journal of pharmaceutics. 2018 Aug 25; 547(1-2):450-68.
    View at Publisher | View at Google Scholar
  23. Kochar IS, Sethi A. Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population. International journal of pediatric endocrinology. 2018 Dec; 2018(1):1-7.
    View at Publisher | View at Google Scholar
  24. Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, et al. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther. 2010; 12:173–7.
    View at Publisher | View at Google Scholar
  25. Luijf YM, van Bon AC, Hoekstra JB, Devries JH. Premeal injection of rapid-acting insulin reduces postprandial glycemic excursions in type 1 diabetes. Diabetes Care. 2010; 33:2152–5.
    View at Publisher | View at Google Scholar
  26. Kramer CK, Retnakaran R, Zinman B. Insulin and insulin analogs as antidiabetic therapy: A perspective from clinical trials. Cell Metabolism. 2021 Apr 6; 33(4):740-7.
    View at Publisher | View at Google Scholar
  27. Sharma DC. Emerging Injectable Therapies in Type 2 Diabetes Mellitus. RSSDI Diabetes Update 2018. 2019 Feb 28:22.
    View at Publisher | View at Google Scholar
  28. Gardner DW, Khan KA, Govindarajan G, Palmer JM, Sowers JR. Type 1 Diabetes Mellitus. InComprehensive Management of High Risk Cardiovascular Patients 2016 Apr 19 (pp. 173-212). CRC Press.
    View at Publisher | View at Google Scholar
  29. Kristl A, Podgornik A, Pompe M. Simultaneous separation of insulin and six therapeutic analogues on a mixed mode column: HPLC-UV method development and application. Journal of Chromatography B. 2021 May 1; 1171:122557.
    View at Publisher | View at Google Scholar
  30. Tupola S, Komulainen J, Jaaskelainen J, Sipila I. Post-prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus. Diabet Med. 2001; 18:654–8.
    View at Publisher | View at Google Scholar
  31. Kumar D. Lispro analog for treatment of generalized allergy to human insulin. Diabetes Care. 1997; 20:1357–9.
    View at Publisher | View at Google Scholar
  32. Heise T, Hovelmann U, Zijlstra E, Stender-Petersen K, Jacobsen JB, Haahr H. A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus. Drugs Aging. 2017; 34:29–38.
    View at Publisher | View at Google Scholar
  33. Ergun-Longmire B, Clemente E, Vining-Maravolo P, Roberts C, Buth K, Greydanus DE. Diabetes education in pediatrics: how to survive diabetes. Disease-a-Month. 2021 Feb 2:101153.
    View at Publisher | View at Google Scholar
  34. Jenkins AJ, Scott E, Fulcher J, Kilov G, Januszewski AS. Management of diabetes mellitus. InComprehensive Cardiovascular Medicine in the Primary Care Setting 2019 (pp. 113-177). Humana Press, Cham.
    View at Publisher | View at Google Scholar
  35. Akudike KP. Formulation and Evaluation of Physical Properties of an Emulsion Based on Lyophilized Snail Mucin for Possible Oral Insulin Delivery (Doctoral dissertation, University of Nigeria Nsukka).
    View at Publisher | View at Google Scholar
  36. Owens DR. Insulin preparations with prolonged effect. Diabetes technology & therapeutics. 2011 Jun 1; 13(S1): S-5.
    View at Publisher | View at Google Scholar
  37. Almadhoun MR. Assessment of Medication Adherence and its Association with Glycemic Control among Type-2 Diabetes Mellitus (T2DM) Patients in Gaza-Palestine (Doctoral dissertation).
    View at Publisher | View at Google Scholar
  38. Chawla R, Chawla A. FAQs in Diabetes. JP Medical Ltd; 2016 Feb 12.
    View at Publisher | View at Google Scholar
  39. Beals JM, DeFelippis MR, Paavola CD, Allen DP, Garg A, Baldwin DB. Insulin. InPharmaceutical biotechnology 2019 (pp. 403-427). Springer, Cham.
    View at Publisher | View at Google Scholar
  40. Mikhael EM, Hassali MA, Hussain SA. A Self-management Guide for Type 2 Diabetes Mellitus Patients from Middle Eastern Countries. Cambridge Scholars Publishing; 2020 Jun 4.
    View at Publisher | View at Google Scholar
  41. Maikawa CL, d’Aquino AI, Lal RA, Buckingham BA, Appel EA. Engineering biopharmaceutical formulations to improve diabetes management. Science Translational Medicine. 2021 Jan 27; 13(578).
    View at Publisher | View at Google Scholar
  42. Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K. (Ultra‐) long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. 2020(11).
    View at Publisher | View at Google Scholar
  43. Yki-Jarvinen H, Dressler A, Ziemen M. Group HOEsS. Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group. Diabetes Care. 2000; 23:1130–6.
    View at Publisher | View at Google Scholar
  44. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care. 2000; 23:639–43.
    View at Publisher | View at Google Scholar
  45. Heise T, Hermanski L, Nosek L, Feldman A, Rasmussen S, Haahr H. Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes. Diabetes Obes Metab. 2012;14:859–64
    View at Publisher | View at Google Scholar
  46. Pettus J, Santos Cavaiola T, Tamborlane WV, Edelman S. The past, present, and future of basal insulins. Diabetes/metabolism research and reviews. 2016 Sep; 32(6):478-96.
    View at Publisher | View at Google Scholar
  47. Hubálek F, Refsgaard HH, Gram-Nielsen S, Madsen P, Nishimura E, Münzel M, Brand CL, Stidsen CE, Claussen CH, Wulff EM, Pridal L. Molecular engineering of safe and efficacious oral basal insulin. Nature communications. 2020 Jul 27; 11(1):1-9.
    View at Publisher | View at Google Scholar
  48. Heise T, Mathieu C. Impact of the mode of protraction of basal insulin therapies on their pharmacokinetic and pharmacodynamic properties and resulting clinical outcomes. Diabetes, Obesity and Metabolism. 2017 Jan; 19(1):3-12.
    View at Publisher | View at Google Scholar
  49. Kennedy-Malone L. Endocrine, Metabolic, and Nutritional Disorders. Advanced Practice Nursing in the Care of Older Adults. 2018 Oct 31:361.
    View at Publisher | View at Google Scholar
  50. Ali MM, Aung KT, Young M, Eligar VS, Davies JS. Different insulin initiation regimens in patients with type 2 diabetes—a review article. Int J Diabetes Clin Res. 2018;5: 083.
    View at Publisher | View at Google Scholar
  51. Giugliano D, Ceriello A, Razzoli E, Esposito K. Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus. Clinical drug investigation. 2008 Apr;28 (4):199-210.
    View at Publisher | View at Google Scholar
  52. Harak KV, Patil PB, Saudhagar RB. Current Challenges in Non-Invasive Insulin Drug Delivery System: A Review. Journal of Drug Delivery and Therapeutics. 2019 Jun 15;9 (3-s):982-8.
    View at Publisher | View at Google Scholar
  53. Kennedy MS, Masharani U. Pancreatic hormones & antidiabetic drugs. Basic and Clinical Pharmacology. New York: McGraw-Hill. 2018:747-1.
    View at Publisher | View at Google Scholar
  54. Banerjee A, Ibsen K, Brown T, Chen R, Agatemor C, Mitragotri S. Ionic liquids for oral insulin delivery. Proceedings of the National Academy of Sciences. 2018 Jul 10;115 (28):7296-301.
    View at Publisher | View at Google Scholar
  55. Meneghini L, Mersebach H, Kumar S, Svendsen AL, Hermansen K, et al. (2011) Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: The step-wise randomized study. Endocr Pract 17: 727-736.
    View at Publisher | View at Google Scholar
  56. Barnett A, Begg A, Dyson P, Feher M, Hamilton S, et al. (2008) Insulin for type 2 diabetes: Choosing a second-line insulin regimen. Int J Clin Pract 62: 1647-1653.
    View at Publisher | View at Google Scholar
  57. Frits H (2014) Insulin Regimens. DIAPEDIA.
    View at Publisher | View at Google Scholar
  58. Cobry E, McFann K, Messer L, Gage V, VanderWel B, Horton L, et al. Timing of meal insulin boluses to achieve optimal postprandial glycemic control in patients with type 1 diabetes. Diabetes Technol Ther. 2010; 12:173–7.
    View at Publisher | View at Google Scholar
  59. Lynn P. Lippincott Photo Atlas of Medication Administration. Lippincott Williams & Wilkins; 2018 Oct 5.
    View at Publisher | View at Google Scholar
  60. Crasto W, Jarvis J, Davies MJ. Practical Aspects of Insulin Therapy. InHandbook of Insulin Therapies 2016 (pp. 169-209). Adis, Cham.
    View at Publisher | View at Google Scholar
  61. Thompson A, Lathan P, Fleeman L. Update on insulin treatment for dogs and cats: insulin dosing pens and more. Veterinary Medicine: Research and Reports. 2015; 6:129.
    View at Publisher | View at Google Scholar
  62. Keijer J, Li M, Speakman JR. What is the best housing temperature to translate mouse experiments to humans?. Molecular metabolism. 2019 Jul 1; 25:168-76.
    View at Publisher | View at Google Scholar
  63. Wanders D, Burk DH, Cortez CC, Van NT, Stone KP, Baker M, Mendoza T, Mynatt RL, Gettys TW. UCP1 is an essential mediator of the effects of methionine restriction on energy balance but not insulin sensitivity. The FASEB Journal. 2015 Jun; 29(6):2603-15.
    View at Publisher | View at Google Scholar
  64. Ngwiri T, Were F, Predieri B, Ngugi P, Iughetti L. Glycemic control in Kenyan children and adolescents with type 1 diabetes mellitus. International journal of endocrinology. 2015 Oct 1; 2015.
    View at Publisher | View at Google Scholar
  65. Paluchamy T. Hypoglycemia: Essential Clinical Guidelines. InBlood Glucose Levels 2019 Sep 30. IntechOpen.
    View at Publisher | View at Google Scholar
  66. Longenecker JZ, Petrosino JM, Martens CR, Hinger SA, Royer CJ, Dorn LE, Branch DA, Serrano J, Stanford KI, Kyriazis GA, Baskin KK. Cardiac-derived TGF-β1 confers resistance to diet-induced obesity through regulation of adipocyte size and function. Molecular Metabolism. 2021 Sep 25:101343.
    View at Publisher | View at Google Scholar
  67. Akinci B, Yener S, Bayraktar F, Yesil S. Allergic reactions to human insulin: a review of current knowledge and treatment options. Endocrine. 2010 Feb; 37(1):33-9.
    View at Publisher | View at Google Scholar
  68. Brown A, Guess N, Dornhorst A, Taheri S, Frost G. Insulin‐associated weight gain in obese type 2 diabetes mellitus patients: What can be done?. Diabetes, Obesity and Metabolism. 2017 Dec; 19(12):1655-68.
    View at Publisher | View at Google Scholar
  69. Greenfield JR, Tuthill A, Soos MA, Semple RK, Halsall DJ, Chaudhry A, O’Rahilly S. Severe insulin resistance due to anti‐insulin antibodies: response to plasma exchange and immunosuppressive therapy. Diabetic Medicine. 2009 Jan; 26(1):79-82.
    View at Publisher | View at Google Scholar
  70. Teegen EM, Dürr M, Maurer MM, Eurich F, Vollbort A, Globke B, Bahra M, Blaeker H, Pratschke J, Eurich D. Evaluation of histological dynamics, kidney function and diabetes in liver transplant patients after antiviral treatment with direct‐acting antivirals: Therapy of HCV‐recurrence. Transplant Infectious Disease. 2019 Feb; 21(1):e13020.
    View at Publisher | View at Google Scholar

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad